1-4 of 4
Tricia Kalafut
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical and Molecular Characterization of Disease Progression in Patients (Pts) with Low-Risk Myelofibrosis (MF) Enrolled in the MOST Study

Abdulraheem Yacoub, Ellen K. Ritchie, Naveen Pemmaraju, Richard Zuniga, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, J.E. Hamer-Maansson, Tricia Kalafut, Evan M. Braunstein, John O. Mascarenhas
Journal: Blood
Blood (2024) 144 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2024-199810
Published: 2024
Journal Articles

Clinical and Disease Characteristics of Patients with Myelofibrosis and Essential Thrombocythemia Who Harbor a Calreticulin (CALR) Gene Mutation: Subanalysis of the MOST Study

Stephen T. Oh, Naveen Pemmaraju, Niyati Nathwani, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, Ellen K. Ritchie
Journal: Blood
Blood (2023) 142 (Supplement 1): 3812.
https://doi.org/10.1182/blood-2023-179507
Published: 2023
Journal Articles

High Rate of Disease Progression in Patients with Low-Risk Myelofibrosis (MF) Enrolled in the Prospective, Real-World MOST Study

Michael R. Grunwald, Aaron T. Gerds, Apurv Agrawal, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, John Mascarenhas
Journal: Blood
Blood (2023) 142 (Supplement 1): 3803.
https://doi.org/10.1182/blood-2023-174523
Published: 2023
Journal Articles

Progression to Myelofibrosis in Patients with Essential Thrombocythemia: A Real-World Analysis from the Prospective MOST Study

Abdulraheem Yacoub, Roger M. Lyons, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, Ruben A. Mesa
Journal: Blood
Blood (2023) 142 (Supplement 1): 2433.
https://doi.org/10.1182/blood-2023-180240
Published: 2023